Abstract
Purpose
To describe the clinical experience and safety profile of a combination of 23-gauge and 20-gauge transconjunctival sutureless vitrectomy (TSV)
Methods
Thirty-seven eyes of thirty-seven consecutive patients who underwent 23-gauge combined with 20-gauge transconjunctival vitrectomy surgery by a single surgeon from August 2006 through December 2006 were reviewed retrospectively for surgical indications, wound problems, and postoperative complications.
Results
Thirty-seven eyes, including eyes with proliferative diabetic retinopathy (n=24), macular hole (n=3), epiretinal membrane (n=3), vitreous hemorrhage due to branch retinal vein occlusion and choroidal neovascular membrane (n=3), vitreous opacity secondary to uveitis (n=1), rhegmatogenous retinal detachment (n=1), and vitreoretinal traction syndrome (n=1), underwent operation. Seven eyes at 23-gauge sclerotomy sites and 15 eyes at 20-gauge sclerotomy sites had subconjunctival hemorrhage. Three eyes required sutures at 20-gauge sclerotomy sites intraoperatively due to wound leakage. One wound hemorrhage occurred at a 23-guage sclerotomy site. Vitreous hemorrhage (4 eyes), hyphema (2 eyes), and vitreous hemorrhage with hyphema (1 eye) occurred postoperatively. Postoperative hypotony, retinal detachment, and other complications did not occur.
References
1. Chen JC. Sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol. 1996; 114:1273–5.
2. Milibak T, Suveges I. Complications of sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol. 1998; 116:119.
3. Kwok AK, Tham CC, Lam DS, et al. Modified sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol. 1999; 127:731–3.
4. Jackson T. Modified sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol. 2000; 129:116–7.
5. Rahman R, Rosen PH, Riddell C, et al. Self-sealing sclerotomies for sutureless pars plana vitrectomy. Ophthalmic Surg Lasers. 2000; 31:462–6.
6. Theelen T, Verbeek AM, Tilanus MA, et al. A novel technique for self-sealing, wedge-shaped pars plana sclerotomies and its features in ultrasound biomicroscopy and clinical outcome. Am J Ophthalmol. 2003; 136:1085–92.
7. Fujii GY, de Juan E Jr, Humayun MS, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002; 109:1807–13.
8. Fujii GY, de Juan E Jr, Humayun MS, et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology. 2002; 109:1814–20.
9. Ibarra MS, Hermel M, Prenner JL, et al. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol. 2005; 139:831–6.
10. Eckardt C. Transconjunctival sutureless 23-guage vitrectomy. Retina. 2005; 25:208–11.
11. Fine HF, Iranmanesh R, Iturralde D, et al. Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease. Ophthalmology. 2007; 114:1197–200.
12. Shimada H, Nakashizuka H, Nakajima M, et al. Twenty-gauge transconjunctival vitrectomy. Jpn J Ophthalmol. 2005; 49:257–60.
13. Gotzaridis EV. Three-port 20-gauge transconjunctival pars plana vitrectomy. Retina. 2007; 27:382–4.
Table 1.
Patients (eyes) | N=37 |
---|---|
Sex | |
Male | 19 |
Female | 18 |
Age (years) | |
Mean±SD | 57±7.4 |
Bilaterality (eyes) | |
OD | 16 |
OS | 21 |
Lens state (eyes) | |
Phakic | 23 |
Pseudophakic | 14 |
Aphakic | 0 |
Intraocular pressure (mmHg) | |
Preoperative day (Mean±SD) | 14±3.2 |
Diagnosis for vitrectomy (eyes) | |
Proliferative diabetic retinopathy | 24 |
Vitreous hemorrhage due to BRVO*, CNV† | 3 |
Vitreous opacity due to uveitis | 1 |
Macular hole | 3 |
Epiretinal membrane | 3 |
Rhegmatogenous retinal detachment | 1 |
Vitreomacular traction syndrome | 1 |
Lens dislocation | 1 |